SHMT1 and cancer: SHMT has been investigated as a possible drug target in cancer and microbial therapeutics, particularly as SHMT expression is tightly regulated with DNA replication during cell division and the enzyme catalyzes the rate-limiting step in dTMP synthesis cycle[3-9].